Cargando…
Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice
Recent reports highlight the potential for integrase-defective lentiviral vectors (IDLV) to be developed as vaccines due to their ability to elicit cell-mediated and humoral immune responses after intramuscular administration. Differently from their integrase-competent counterpart, whose utility for...
Autores principales: | Fontana, Judith M., Christos, Paul J., Michelini, Zuleika, Negri, Donatella, Cara, Andrea, Salvatore, Mirella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019533/ https://www.ncbi.nlm.nih.gov/pubmed/24824623 http://dx.doi.org/10.1371/journal.pone.0097270 |
Ejemplares similares
-
Intranasal Administration of Integrase Defective Lentiviral Vectors Expressing mAbs Protects from H5 Influenza Virus Challenge In Vivo
por: Michelini, Zuleika, et al.
Publicado: (2017) -
Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
por: Michelini, Zuleika, et al.
Publicado: (2020) -
Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
por: Rossi, Alessandra, et al.
Publicado: (2014) -
Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
por: Gallinaro, Alessandra, et al.
Publicado: (2018) -
Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
por: Morante, Valeria, et al.
Publicado: (2021)